Cardiogenic and hypovolemic shock.
The symptoms, signs, and pathophysiology of two major forms of shock are discussed. Newer modalities of pharmacologic and supportive therapy for stabilization and reversal of these states are presented, including the use of the intra-aortic balloon pump and early surgical therapy for cardiogenic shock.
R A
RA
Billhardt
S W
SW
Rosenbush
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001794:Blood Pressure; D002305:Cardiac Tamponade / Q000150:complications; D003102:Colloids; D000077324:Crystalloid Solutions; D004064:Digestive System / Q000503:physiopathology; D005440:Fluid Therapy; D006321:Heart / Q000503:physiopathology; D006801:Humans; D007423:Intra-Aortic Balloon Pumping; D007552:Isotonic Solutions; D007668:Kidney / Q000503:physiopathology; D008168:Lung / Q000503:physiopathology; D008991:Monitoring, Physiologic; D009203:Myocardial Infarction / Q000503:physiopathology; D009292:Narcotic Antagonists / Q000627:therapeutic use; D009420:Nervous System / Q000503:physiopathology; D010952:Plasma Substitutes / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000150:complications; D012769:Shock / Q000503:physiopathology / Q000628:therapy*; D012770:Shock, Cardiogenic / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*
D000305:Adrenal Cortex Hormones; D003102:Colloids; D000077324:Crystalloid Solutions; D007552:Isotonic Solutions; D009292:Narcotic Antagonists; D010952:Plasma Substitutes